Abstract
Introduction: The nephrotoxicity induced by the immunosuppressive drug FK506, limits its usefulness in widespread application, and the underlying mechanism has not been completely understood. The primary targets of FK506 in the kidney are the proximal tubular epithelial cells. In this study, the protection of green tea extract against FK506-induced cell death of LLC-PK1 cells was investigated. Results: FK506 caused a significant decrease in survival of the cells, but the addition of green tea extract reduced this effect in a dose-dependent manner. Treatment of the cells with 50 μM FK506 induced a significant increase in annexin V-positive/PI-negative cells from 2.68 to 14.5%, whereas the addition of 6.25, 12.5, 25 μg/ml of green tea extract caused a significant protective effect in apoptotic cells from 14.5 to 6.51, 3.20 and 3.02%, respectively. The effect of five different constituent tea polyphenols was also examined. Epigallocatechin gallate (EGCG) and epigallocatechin (EGC) significantly reduced FK506-induced cytotoxicity but epicatechin (EC) and catechin (C) had no effect on cell viability. Furthermore, changes in cytochrome c release and caspase activation, which characterize apoptosis, were studied. EGCG and EGC suppressed a significant release of cytochrome c and activation of caspase-3 in FK506-treated LLC-PK1 cells. Conclusion: FK506 caused a significant increase in apoptotic cells but the addition of GTE, and particularly its major polyphenolic components EGC and EGCG, suppressed the cell death.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.